Restor+ is a minimally manipulated allograft derived from the umbilical cord tissue layer of Wharton’s Jelly and processed to maximize concentration. Restor+ is for homologous use and is intended to enhance the body’s natural ability to heal.
Restor+ works by secreting powerful bioactive molecules. Restor+ contains a network of scaffolding proteins, growth factors, cytokines, extracellular matrix, and multiple other components needed to create a healing environment.
Restor+ umbilical cord tissues lack MHC-II and are, therefore, hypo-immunogenic. Consequently, there is minimal risk of an allergic reaction for the recipient.
Restor+ has a strong anti-inflammatory effect reducing the expression of inflammatory cytokines.
Restor+ has a higher proliferation rate when compared to autologous tissue such as adipose or bone marrow. Restor+ is less invasive compared to other regenerative medicine forms, such as bone marrow or adipose tissue extraction; this results in less pain and rehabilitation time for the patient.
Restor+ is recovered from healthy, carefully screened mothers at the time of delivery. All protocols are in accordance with the FDA, AATB, and AABB regulations and standards.
Restor+ may be an ideal choice for individuals dealing with various conditions that interfere with their everyday lives, especially those over the age of fifty who, due to the aging process, may have less viable components than a younger person might.